Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura C Coates

Showing results (191-200 of 342) with videos related to

Pageof 35
Sort By:
Rheumatology (Oxford, England)|March 15, 2024
Enhancing current guidance for psoriatic arthritis and its comorbidities: recommendations from an expert consensus panelLaura C Coates, Marwan Bukhari, Antoni Chan, et al.
The Journal of Rheumatology|August 15, 2023
Screening and Referral Strategies for the Early Recognition of Psoriatic Arthritis Among Patients With Psoriasis: Results of a GRAPPA SurveyKaiyang Song, Louisa Webb, Lihi Eder, et al.
The Journal of Rheumatology. Supplement|June 3, 2018
GRAPPA 2017 Project ReportKristina Callis Duffin, Oliver FitzGerald, Artie Kavanaugh, et al.
The Journal of Rheumatology|November 3, 2019
Comparing Psoriatic Arthritis Low-field Magnetic Resonance Imaging, Ultrasound, and Clinical Outcomes: Data from the TICOPA TrialPhilip S Helliwell, Laura C Coates, Ne Siang Chew, et al.
The Journal of Rheumatology|October 17, 2019
Effect of Secukinumab on the Different GRAPPA-OMERACT Core Domains in Psoriatic Arthritis: A Pooled Analysis of 2049 PatientsAna-Maria Orbai, Iain B McInnes, Laura C Coates, et al.
Rheumatology and Therapy|December 2, 2023
Correction: Post-Marketing Safety Surveillance of Tofacitinib over 9 Years in Patients with Psoriatic Arthritis and Rheumatoid ArthritisGerd R Burmester, Laura C Coates, Stanley B Cohen, et al.
Arthritis Care & Research|March 26, 2024
Improvements in Patient-Reported Outcomes After Treatment With Deucravacitinib in Patients With Psoriatic Arthritis: Results From a Randomized Phase 2 TrialVibeke Strand, Laure Gossec, Laura C Coates, et al.
Rheumatology (Oxford, England)|January 13, 2024
Comparative efficacy and safety of bimekizumab in psoriatic arthritis: a systematic literature review and network meta-analysisPhilip J Mease, Dafna D Gladman, Joseph F Merola, et al.
Rheumatology and Therapy|July 17, 2023
Post-Marketing Safety Surveillance of Tofacitinib over 9 Years in Patients with Psoriatic Arthritis and Rheumatoid ArthritisGerd R Burmester, Laura C Coates, Stanley B Cohen, et al.
Lancet (London, England)|October 5, 2015
Effect of tight control of inflammation in early psoriatic arthritis (TICOPA): a UK multicentre, open-label, randomised controlled trialLaura C Coates, Anna R Moverley, Lucy McParland, et al.
Pageof 35

Showing results (191-200 of 342) with videos related to

Sort By:
Pageof 35
Rheumatology (Oxford, England)|March 15, 2024
Enhancing current guidance for psoriatic arthritis and its comorbidities: recommendations from an expert consensus panelLaura C Coates, Marwan Bukhari, Antoni Chan, et al.
The Journal of Rheumatology|August 15, 2023
Screening and Referral Strategies for the Early Recognition of Psoriatic Arthritis Among Patients With Psoriasis: Results of a GRAPPA SurveyKaiyang Song, Louisa Webb, Lihi Eder, et al.
The Journal of Rheumatology. Supplement|June 3, 2018
GRAPPA 2017 Project ReportKristina Callis Duffin, Oliver FitzGerald, Artie Kavanaugh, et al.
The Journal of Rheumatology|November 3, 2019
Comparing Psoriatic Arthritis Low-field Magnetic Resonance Imaging, Ultrasound, and Clinical Outcomes: Data from the TICOPA TrialPhilip S Helliwell, Laura C Coates, Ne Siang Chew, et al.
The Journal of Rheumatology|October 17, 2019
Effect of Secukinumab on the Different GRAPPA-OMERACT Core Domains in Psoriatic Arthritis: A Pooled Analysis of 2049 PatientsAna-Maria Orbai, Iain B McInnes, Laura C Coates, et al.
Rheumatology and Therapy|December 2, 2023
Correction: Post-Marketing Safety Surveillance of Tofacitinib over 9 Years in Patients with Psoriatic Arthritis and Rheumatoid ArthritisGerd R Burmester, Laura C Coates, Stanley B Cohen, et al.
Arthritis Care & Research|March 26, 2024
Improvements in Patient-Reported Outcomes After Treatment With Deucravacitinib in Patients With Psoriatic Arthritis: Results From a Randomized Phase 2 TrialVibeke Strand, Laure Gossec, Laura C Coates, et al.
Rheumatology (Oxford, England)|January 13, 2024
Comparative efficacy and safety of bimekizumab in psoriatic arthritis: a systematic literature review and network meta-analysisPhilip J Mease, Dafna D Gladman, Joseph F Merola, et al.
Rheumatology and Therapy|July 17, 2023
Post-Marketing Safety Surveillance of Tofacitinib over 9 Years in Patients with Psoriatic Arthritis and Rheumatoid ArthritisGerd R Burmester, Laura C Coates, Stanley B Cohen, et al.
Lancet (London, England)|October 5, 2015
Effect of tight control of inflammation in early psoriatic arthritis (TICOPA): a UK multicentre, open-label, randomised controlled trialLaura C Coates, Anna R Moverley, Lucy McParland, et al.
Pageof 35